OriGene Developing Antibodies for SISCAPA Assays with NCI Contract GenomeWeb NEW YORK (GenomeWeb News) – OriGene Technologies announced that it has received a contract from the National Cancer Institute to develop high affinity anti-peptide antibodies for SISCAPA assays. SISCAPA, short for Stable Isotope Standards and ... |
